Akèy › Leukemi › Iowa › Cedar Rapids

Etid klinik pou Leukemi nan Cedar Rapids, IA

6 etid pou Leukemi ap chèche patisipan nan sit nan ak bò kote Cedar Rapids (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

Ap rekriteFaz 1/2

University of Iowa Hospital, Iowa City · 25 mi lwen

30 Days · Tout sèks · Mizajou Sep 16, 2026 · NCT04065399

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Ap rekriteFaz 1

University of Iowa Hospitals & Clinics, Iowa City · 25 mi lwen

Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT06001788

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Ap rekriteFaz 3

University of Iowa, Iowa City · 25 mi lwen

Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT07007312

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Ap rekriteFaz 1

University of Iowa Hospitals & Clinics, Iowa City · 25 mi lwen

Laj 18 ak plis · Tout sèks · Mizajou Mar 13, 2026 · NCT05735184

Activity Levels in Bone Marrow Transplant Patients

Ap rekriteEtid obsèvasyon

University of Iowa, Iowa City · 25 mi lwen

Laj 18 a 99 · Tout sèks · Mizajou Nov 10, 2025 · NCT04115241

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon

Massive Bio SYNERGY-AI site, Iowa City · 25 mi lwen

Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Etid Leukemi nan lòt vil

Lòt etid nan Cedar Rapids

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.